The Inflation Reduction Act (IRA) represents a landmark policy change in the United States. Shifting financial responsibilities and benefit structures will change product strategies, risk-sharing models, and behaviors.

In this webinar we will examine potential direct and indirect impacts to stakeholders including pharmaceutical and biotech manufacturers, payers, physicians, and patients.

This webinar will feature Lumanity’s subject matter experts regarding benefits, product pricing, and access. We will make recommendations to help manufacturers improve decisions as the IRA is implemented.

Webinar – Thursday, February 9, 2023

10:00-11:00am EDT / 15:00-16:00pm GMT


Nancy McGee, JD, MPH, DrPH

Senior Vice President, Health Policy and Public Payers, Lumanity

Tom Murtagh, MBA

Managing Director and Founder Clarion, a Lumanity Business

Amber Gilbert, MBA

Global President, Market Access, Lumanity

Ron Akehurst, Executive Chairman at Lumanity

Ron Akehurst, BSc, DSc, MFPH

Executive Chair, HEOR, Lumanity